Vascular abnormalities in primary amyloidosis

European Heart Journal

Volumn 28, Issue 8, 2007, Pages 1019-1024

  Modesto, Karen M ^a   Dispenzieri, Angela ^a   Gertz, Morie ^a   Cauduro, Sanderson A ^a   Khandheria, Bijoy K ^a   Seward, James B ^a   Kyle, Robert ^a   Wood, Christina M ^a   Bailey, Kent R ^a   Tajik, Abdel Jamil ^a   Miller, Fletcher A ^a   Pellikka, Patricia A ^a   Abraham, Theodore P ^a,b  

^a MAYO CLINIC   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Amyloidosis; Endothelial function; Flow mediated arterial dilatation; Intimal medial thickness

Indexed keywords

AMYLOID;

ADULT; ARTERY DILATATION; ARTERY INTIMA PROLIFERATION; ARTICLE; BRACHIAL ARTERY; CAROTID ARTERY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; FEMALE; HEART AMYLOIDOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; VALIDATION STUDY; VOLUNTEER;

AGED; AMYLOIDOSIS; BRACHIAL ARTERY; CAROTID ARTERIES; DILATATION, PATHOLOGIC; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; TUNICA INTIMA; VASCULAR DISEASES;

EID: 34548308828     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehm066     Document Type: Article

References (32)

1. Gertz MA, Lacy MQ, Dispenzieri A. Amyloidosis: recognition, confirmation, prognosis, and therapy. Mayo Clin Proc 1999;74:490-494.
2. Al Suwaidi J, Velianou JL, Gertz MA, Cannon RO III, Higano ST, Holmes DR Jr, Lerman A. Systemic amyloidosis presenting with angina pectoris. Ann Intern Med 1999;131:838-841.
3. Berghoff M, Kathpal M, Khan F, Skinner M, Falk R, Freeman R. Endothelial dysfunction precedes C-fiber abnormalities in primary (AL) amyloidosis. Ann Neurol 2003;53:725-730.
4. Churchill CH, Abril A, Krishna M, Callman ML, Ginsburg WW. Jaw claudication in primary amyloidosis: unusual presentation of a rare disease. J Rheumatol 2003;30:2283-2286.
5. Gertz MA, Kyle RA, Griffing WL, Hunder GG. Jaw claudication in primary systemic amyloidosis. Medicine (Baltimore) 1986;65:173-179.
6. Ishikawa Y, Ishii T, Masuda S, Asuwa N, Kiguchi H, Hirai S, Murayama A. Myocardial ischemia due to vascular systemic amyloidosis: a quantitative analysis of autopsy findings on stenosis of the intramural coronary arteries. Pathol Int 1996;46:189-194.
7. Smestad C, Monstad P, Lindboe CF, Mygland A. Amyloid myopathy presenting with distal atrophic weakness. Muscle Nerve 2004;29:605-609.
8. Whitaker DC, Tungekar MF, Dussek JE. Angina with a normal coronary angiogram caused by amyloidosis. Heart 2004;90:e54.
9. Hoffman R, Lethen H, Marwick T, Arnese M, Fioretti P, Pingitore A, Picano E, Buck T, Erber R, Flachskampf FA, Hanrath P. Analysis of interinstitutional observer agreement in interpretation of dobutamine stress echocardiograms. J Am Coll Cardiol 1996;27:330-336.
10. Grcevska L, Polenakovic M. Primary amyloidosis - involving principally intrarenal blood vessels. Nephrol Dial Transplant 1993;8:296-300.
11. Smith TJ, Kyle RA, Lie JT. Clinical significance of histopathologic patterns of cardiac amyloidosis. Mayo Clinic Proc 1984;59:547-555.
12. Yamano S, Motomiya K, Akai Y, Shiiki H, Toyama T, Hashimoto T, Fujimoto S, Nakamura S, Fukuoka Y. Primary systemic amyloidosis presenting as angina pectoris due to intramyocardial coronary artery involvement: a case report. Heart Vessels 2002;16:157-160.
13. Waters DD, Da Luz P, Wyatt HL, Swan HJ, Forrester JS. Early changes in regional and global left ventricular function induced by graded reductions in regional coronary perfusion. Am J Cardiol 1977;39:537-543.
14. Riley WA, Evans GW, Sharrett AR, Burke GL, Barnes RW. Variation of common carotid artery elasticity with intimal-medial thickness: the ARIC Study. Atherosclerosis Risk in Communities. Ultrasound Med Biol 1997;23:157-164.
15. Kramer CM, Lima JA, Reichek N, Ferrari VA, Llaneras MR, Palmon LC, Yeh IT, Tallant B, Axel L. Regional differences in function within noninfarcted myocardium during left ventricular remodeling. Circulation 1993;88:1279-1288.
16. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111-1115.
17. Lima DS, Sato EI, Lima VC, Miranda F Jr, Hatta FH. Brachial endothelial function is impaired in patients with systemic lupus erythematosus. J Rheumatol 2002;29:292-297.
18. Neunteufl T, Heher S, Stefenelli T, Pabinger I, Gisslinger H. Endothelial dysfunction in patients with polycythaemia vera. Br J Haematol 2001;115:354-359.
19. Cueto-Garcia L, Reeder GS, Kyle RA, Wood DL, Seward JB, Naessens J, Offord KP, Greipp PR, Edwards WD, Tajik AJ. Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival. J Am Coll Cardiol 1985;6:737-743.
20. Plotnick GD, Corretti MC, Vogel RA. Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal. JAMA 1997;278:1682-1686.
21. Rosner B. Fundamentals of Biostatistics. Pacific Grove, CA: Duxbury Press; 2000. p792.
22. Kramer MS, Feinstein AR. Clinical biostatistics. LIV. The biostatistics of concordance. Clin Pharmacol Ther 1981;29:111-123.
23. Baldassarre D, Amato M, Bondioli A, Sirtori CR, Tremoli E. Carotid artery intima-media thickness measured by ultrasonography in normal clinical practice correlates well with atherosclerosis risk factors. Stroke 2000;31:2426-2430.
24. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111-1115.
25. Celermajer DS, Adams MR, Clarkson P, Robinson J, McCredie R, Donald A, Deanfield JE. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med 1996;334:150-154.
26. Davis PH, Dawson JD, Riley WA, Lauer RM. Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: the Muscatine Study. Circulation 2001;104:2815-2819.
27. Taddei S, Salvetti A. Endothelial dysfunction in essential hypertension: clinical implications. J Hypertens 2002;20:1671-1674.
28. Crotty T, Cy L, Edwards W, Suman V. Amyloidosis and endomyocardial biopsy: correlation of extent and pattern of deposition with amyloid immunophenotype in 100 cases. Cardiovasc Pathol 1995;4:39-42.
29. Smith RR, Hutchins GM. Ischemic heart disease secondary to amyloidosis of intramyocardial arteries. Am J Cardiol 1979;44:413-417.
30. Cheung YF, Chan GC, Ha SY. Arterial stiffness and endothelial function in patients with beta-thalassemia major. Circulation 2002;106:2561- 2566.
31. Brenner DA, Jain M, Pimentel DR, Wang B, Connors LH, Skinner M, Apstein CS, Liao R. Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress. Circ Res 2004;94:1008-1010.
32. Abraham RS, Geyer SM, Price-Troska TL, Allmer C, Kyle RA, Gertz MA, Fonseca R. Immunoglobulin light chain variable (V) region genes influence clinical presentation and outcome in light chain-associated amyloidosis (AL). Blood 2003;101:3801-3808.